Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
HIV Medicine|June 11, 2014
Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapyA Torres-Cornejo, O J Benmarzouk-Hidalgo, A Gutierrez-Valencia, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2013
Immune activation throughout a boosted darunavir monotherapy simplification strategyO J BenMarzouk-Hidalgo, A Torres-Cornejo, A Gutiérrez-Valencia, et al.Journal of Viral Hepatitis|January 21, 2014
Impact of the peginterferon-α 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypesA Torres-Cornejo, R Ruiz-Valderas, L Jimenez-Jimenez, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 11, 2015
Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tractA Torres-Cornejo, O J BenMarzouk-Hidalgo, P Viciana, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 28, 2015
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopeniaJ A Mira, K Neukam, L F López-Cortés, et al.Pageof 1